Chemical Information:
- Molecular Formula: C₁₅₂H₂₅₂N₄₄O₄₂
- Molecular Weight: 3367.99 g/mol
- Sequence: Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Asp-Ile-Met-Ser-Arg-Lys-Lys-Gln-Gln-Phe-Gln-Gly-Leu-Arg-Lys-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser
- Molecular Structure: Refer to Certificate of Analysis for detailed structural information.
Description:
CJC-1295 no DAC is a synthetic peptide analog of growth hormone-releasing hormone (GHRH). In laboratory research, it has been studied for its potential to stimulate endogenous growth hormone (GH) secretion from the anterior pituitary gland. Provided in lyophilized powder form, this peptide maintains optimal stability and integrity during storage and research applications.
Research Applications:
Laboratory studies involving CJC-1295 no DAC typically explore:
- Growth Hormone Secretion: Investigating the peptide’s potential role in triggering the release of growth hormone within controlled experimental conditions.
- Cellular Repair Processes: Evaluating effects on cellular regeneration and tissue repair pathways in preclinical research models.
- Metabolic Function: Exploring possible impacts on metabolic processes, including lipid metabolism and lean muscle preservation in laboratory settings.
Storage and Handling:
- Store lyophilized peptide at -20°C.
- After reconstitution, store at 2-8°C and use promptly.
- Maintain aseptic handling practices to ensure sterility and product integrity.
Product Specifications:
- Purity: ≥99% (HPLC Verified)
- Appearance: Lyophilized white powder
- Solubility: Soluble in bacteriostatic water
Important Note:
This product is strictly FOR RESEARCH USE ONLY and is intended exclusively for in vitro research and laboratory experimentation by qualified professionals. It is not a drug, food, cosmetic, or dietary supplement, and has not been evaluated by the FDA. This peptide is not intended to diagnose, treat, cure, or prevent any disease. The bodily introduction into humans or animals is strictly prohibited by law. Any misuse, misbranding, or mislabeling is a violation of federal regulations and may result in legal action under applicable federal, state, or local laws.
References:
Referenced scientific publications include:
- Ipsen, J., et al. (2004). “Effects of GHRH Analogs on Growth Hormone Release.” Endocrine Research Journal.
- Clark, R., et al. (2010). “CJC-1295 and the Regulation of Metabolic Pathways.” Peptide Science Quarterly.
Reviews
There are no reviews yet.